Best Peptide Protocols
    Hormonal / Growth HormoneBlend

    CJC-1295 + Ipamorelin 10mg blend: Dosage, Reconstitution & Research Protocol Guide

    Dosing ranges, reconstitution steps, administration details, cycle length, and storage guidance for CJC-1295 + Ipamorelin (5mg/5mg Vial).

    Strength & Form:5mg/5mg Vial
    CJC-1295 + Ipamorelin (5mg/5mg Vial) peptide vial

    CJC-1295 + Ipamorelin (5mg/5mg Vial)

    10 mg blend Research Peptide

    Shop on ResearchLabs

    Quick Facts

    Type
    Blend
    Category
    Hormonal / Growth Hormone
    Vial Strength
    10 mg blend
    Status
    Research

    Research Purposes Only

    This information is provided for educational purposes only. This content is not intended to diagnose, treat, cure, or prevent any disease. Always consult with qualified healthcare professionals.

    Download Guide

    Save the complete CJC-1295 + Ipamorelin 10mg blend research guide as a PDF.

    Educational and research use only. Not medical advice.

    Reference

    Sources used for this guide are listed in our research database .

    What Is CJC-1295 + Ipamorelin 10mg blend?

    CJC-1295 + Ipamorelin 10mg blend Vial Overview

    The most widely studied GH secretagogue combination. CJC-1295 (no DAC) stimulates GH via the GHRH receptor while Ipamorelin activates the ghrelin receptor, producing synergistic GH pulses 5–10x greater than either alone.

    CJC-1295 + Ipamorelin 10mg blend Quick Reference

    CJC-1295 + Ipamorelin 10mg blend Vial Specifications

    Peptide
    CJC-1295 + Ipamorelin (5mg/5mg Vial) (NNMT inhibitor)
    Vial Content
    CJC-1295 (no DAC) 5 mg + Ipamorelin 5 mg per vial
    Category
    Hormonal / Growth Hormone
    Administration Method
    Subcutaneous injection
    Common Use Case
    Synergistic growth hormone optimization

    CJC-1295 + Ipamorelin 10mg blend Compared With Other Formats

    Details that distinguish this 10 mg blend format include:

    • Most popular GH secretagogue combination
    • Dual-receptor GH stimulation
    • Clean GH release with minimal side effects
    • Synergistic pulse 5–10× greater than either alone

    How Does CJC-1295 + Ipamorelin Work?

    CJC-1295 + Ipamorelin Mechanism of Action

    CJC-1295 (no DAC) stimulates growth hormone release via the GHRH receptor, providing a sustained GH-releasing signal. Ipamorelin activates the ghrelin/GHS receptor for a clean, selective GH pulse without significant cortisol or prolactin elevation. The dual-receptor activation produces amplified, synergistic GH secretion.

    What Are the Potential Benefits of CJC-1295 + Ipamorelin?

    CJC-1295 + Ipamorelin Research Findings and Observed Outcomes

    Findings and reported areas of study for CJC-1295 + Ipamorelin (5mg/5mg Vial) include:

    • Amplified GH pulses (5–10× single-agent levels)
    • Improved body composition
    • Enhanced recovery and sleep quality
    • Increased IGF-1 levels
    • Minimal cortisol and prolactin elevation

    These observations are discussed for research and educational reference only and are not medical claims.

    What Do You Need to Reconstitute CJC-1295 + Ipamorelin 10mg blend?

    CJC-1295 + Ipamorelin 10mg blend Supplies for Reconstitution and Handling

    • •CJC-1295 + Ipamorelin blend vial (10 mg)
    • •Bacteriostatic water
    • •3 mL mixing syringe with 21g needle
    • •U-100 insulin syringes (29–31g)
    • •Alcohol swabs

    Supplies listed are for laboratory handling and research preparation purposes only.

    CJC-1295 + Ipamorelin 10mg blend Administration and Research Protocol

    CJC-1295 + Ipamorelin Injection Route, Frequency and Timing

    RouteSubcutaneous injection
    Frequency1–2 times daily
    TimingBefore bed (primary) and/or morning fasted

    Best administered on an empty stomach — avoid food 1 hour before and after. Pre-bed dosing aligns with natural GH secretion patterns.

    CJC-1295 + Ipamorelin 10mg blend Dosage Guide

    CJC-1295 + Ipamorelin Dosage Ranges

    The ranges below pair the listed dose with the draw volume for this product strength.

    Low Range100 mcg CJC + 100 mcg Ipa (200 mcg total)
    Standard Range150 mcg CJC + 150 mcg Ipa (300 mcg total)
    Upper Range200 mcg CJC + 200 mcg Ipa (400 mcg total)

    CJC-1295 + Ipamorelin 10mg blend Dosage to Syringe Units

    Based on reconstitution below

    Target Daily DoseDraw VolumeUnits
    200 mcg total0.04 mL4 units
    300 mcg total0.06 mL6 units
    400 mcg total0.08 mL8 units

    This dosing table is unique to the 10 mg blend vial. Units refer to markings on a standard U-100 insulin syringe (1 unit = 0.01 mL).

    How Long Does a CJC-1295 + Ipamorelin 10mg blend Vial Last?

    CJC-1295 + Ipamorelin 10mg blend Duration by Research Dose

    At common research doses, one 10 mg blend vial of CJC-1295 + Ipamorelin typically supports:

    100 mcg CJC + 100 mcg Ipa (200 mcg total)12–16 weeks
    150 mcg CJC + 150 mcg Ipa (300 mcg total)8–12 weeks
    200 mcg CJC + 200 mcg Ipa (400 mcg total)8 weeks

    How to Reconstitute CJC-1295 + Ipamorelin 10mg blend

    CJC-1295 + Ipamorelin 10mg blend Reconstitution With Bacteriostatic Water

    This section applies specifically to the CJC-1295 + Ipamorelin (5mg/5mg Vial).

    Recommended Diluent
    Bacteriostatic water (BAC water)
    Diluent Volume
    2 mL
    Final Concentration
    5 mg/mL total blend (2.5 mg/mL each peptide)

    CJC-1295 + Ipamorelin 10mg blend Mixing Instructions

    1. 1Remove the vial from storage and allow it to reach room temperature (10–15 minutes).
    2. 2Wash hands thoroughly and prepare a clean workspace with all supplies.
    3. 3Using a sterile syringe, draw the appropriate volume of bacteriostatic water.
    4. 4Clean the rubber stopper of the vial with an alcohol prep pad.
    5. 5Insert the needle at a slight angle and slowly inject the diluent down the inner wall of the vial.
    6. 6Gently swirl or roll the vial until fully dissolved; the solution should appear clear and colorless.
    7. 7Label the vial with reconstitution date and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light. Use within 2–4 weeks.

    CJC-1295 + Ipamorelin Stacks and Research Combinations

    CJC-1295 + Ipamorelin and Compatible Research Pairings

    In research settings, CJC-1295 + Ipamorelin (5mg/5mg Vial) is sometimes paired with peptides such as:

    • MK-677: Sustained GH elevation between injections
    • BPC-157 + TB-500: Recovery support alongside GH optimization
    • Tesamorelin: Enhanced GHRH signaling (advanced protocols)

    Avoid stacking with other GHRH analogs unless experienced — can cause desensitization.

    Factors That May Affect CJC-1295 + Ipamorelin Research Outcomes

    Supporting Factors for CJC-1295 + Ipamorelin Research

    Factors recorded alongside this protocol include:

    • Avoid carbohydrates 2 hours before injection (insulin blunts GH)
    • Prioritize deep sleep
    • Regular resistance training to maximize GH utilization
    • Adequate protein intake

    These factors can affect how research observations are interpreted.

    CJC-1295 + Ipamorelin Side Effects and Safety Considerations

    CJC-1295 + Ipamorelin 10mg blend Tolerability Notes

    One of the best-tolerated GH secretagogue combinations

    Some individuals report:

    • Mild tingling or flushing post-injection
    • Increased hunger (usually mild)
    • Water retention during first 1–2 weeks
    • Vivid dreams / improved sleep depth
    • Occasional headache

    How to Store CJC-1295 + Ipamorelin Before and After Reconstitution

    CJC-1295 + Ipamorelin 10mg blend Storage Requirements

    Unreconstituted
    Room temperature or refrigerated
    Reconstituted
    Refrigerate (2–8°C)
    Post-Mix Stability
    Use within 28 days after reconstitution

    Who Should Avoid CJC-1295 + Ipamorelin?

    This peptide is generally not recommended for:

    • Those with active cancer or tumors
    • Those with uncontrolled diabetes
    • Pregnant or breastfeeding individuals

    CJC-1295 + Ipamorelin 10mg blend FAQs

    Why is this the most popular GH blend?

    CJC-1295 + Ipamorelin activates two distinct receptors (GHRH-R and GHS-R), producing synergistic GH pulses far greater than either peptide alone, with minimal side effects compared to GHRP-2 or GHRP-6.

    Should I take this before bed or in the morning?

    Pre-bed is most common as it aligns with natural nocturnal GH secretion. Advanced protocols add a morning fasted dose. Always on an empty stomach.

    Is this the same as CJC-1295 with DAC?

    No — this blend uses CJC-1295 without DAC (also called Mod GRF 1-29), which has a shorter half-life producing pulsatile GH release. DAC versions create sustained elevation, which is a different protocol.

    Where to Buy CJC-1295 + Ipamorelin 10mg blend for Research

    CJC-1295 + Ipamorelin 10mg blend Purchasing and Research Supply Notes

    Before ordering CJC-1295 + Ipamorelin (5mg/5mg Vial), review the product label, available testing documents, and storage instructions.

    Check the ResearchLabs listing for:

    • Available testing documents
    • Product strength and concentration
    • Storage and handling instructions
    • Current product availability

    View the current listing for CJC-1295 + Ipamorelin (5mg/5mg Vial):

    → View on ResearchLabs

    Confirm the product strength and storage requirements before ordering. Products are for laboratory research only and are not for human consumption.

    Related Hormonal / Growth Hormone Peptides